Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Klaus Peter Bogeso"'
Autor:
Connie Sanchez, Krestian Larsen, Peter Bregnedal, Benny Bang-Andersen, Sid Topiol, Klaus Peter Bogeso, Claus J. Loland, Per Plenge, Karsten Juhl
Publikováno v:
Topiol, S, Bang-Andersen, B, Sanchez, C, Plenge, P, Loland, C J, Juhl, K, Larsen, K, Bregnedal, P & Bogeso, K P 2017, ' X-ray structure based evaluation of analogs of citalopram : Compounds with increased affinity and selectivity compared with R-citalopram for the allosteric site (S2) on hSERT ', Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 3, pp. 470-478 . https://doi.org/10.1016/j.bmcl.2016.12.037
The recent publication of X-ray structures of SERT includes structures with the potent antidepressant S-Citalopram (S-Cit). Earlier predictions of ligand binding at both a primary (S1) and an allosteric modulator site (S2), were confirmed. We provide
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 26:5058-5064
The recently reported X-ray structures of the human serotonin (5-HT) transporter SERT with bound inhibitors open new opportunities for drug discovery at SERT, selectivity design with respect to other neurotransmitter sodium transporters, and enhanced
Autor:
M. Andreas B. Larsen, Jonas N. N. Eildal, Benny Bang-Andersen, Jacob Andersen, Claus J. Loland, Per Plenge, Anders S. Kristensen, Klaus Peter Bogeso, Kristian Strømgaard, Ulrik Gether
Publikováno v:
British Journal of Pharmacology. 173:925-936
Background and purpose The 5-HT transporter (SERT) is a target for antidepressant drugs. SERT possesses two binding sites: the orthosteric (S1) binding site, which is the presumed target for current SERT inhibitors, and an allosteric (S2) site for wh
Publikováno v:
Transporters as Drug Targets
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efb0380a63d4cf5fe9cf15532122d66c
https://doi.org/10.1002/9783527679430.ch2
https://doi.org/10.1002/9783527679430.ch2
Publikováno v:
Allosterism in Drug Discovery ISBN: 9781782624592
The serotonin transporter (SERT) is an important drug target and the majority of currently used antidepressants are potent inhibitors of SERT, binding primarily to the substrate binding site. However, even though the existence of an allosteric modula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::199157ad1f66050b1ab33b2d71d496e7
https://doi.org/10.1039/9781782629276-00360
https://doi.org/10.1039/9781782629276-00360
Autor:
Connie Sanchez, Klaus Peter Bogeso
Publikováno v:
Analogue-Based Drug Discovery III
Autor:
Klaus Peter Bogeso
Publikováno v:
Neurochemical Research. 39:1847-1849
Povl Krogsgaard-Larsen is a true giant in medicinal chemistry and without doubt the person that has had the greatest impact on this discipline in Denmark. I got to know Povl in the spring of 1970. After I had finished my chemical engineer education,
Publikováno v:
Acta Pharmacologica et Toxicologica. 41:103-120
The release from the depot, hydrolysis and distribution in the organism as well as the metabolism and elimination of intramuscularly injected Clopenthixol decanoate in Viscoleo® have been studied in dogs and rats with radioactive as well as non-labe
Autor:
Balázs Gulyás, Magnus Schou, Christer Halldin, Judit Sovago, Klaus Peter Bogeso, Lars Farde, Victor W. Pike
Publikováno v:
Molecular Imaging and Biology. 8:1-8
Desipramine (DMI), talopram and talsupram, three of the most potent norepinephrine transporter (NET) inhibitors reported to date, were radiolabeled in high yields and at high specific radioactivity (58-75 GBq/micromol) by the methylation of nor-precu
Autor:
Povl Krogsgaard-Larsen, Eddi Meier, Hans Bräuner-Osborne, Klaus Peter Bogeso, Richard G. Ball, Henrik Pedersen, Karla Frydenvang
Publikováno v:
University of Copenhagen
A series of O- and ring-alkylated derivatives of 4,5,6,7-tetrahydroisothiazolo[4,5-c]pyridin-3-ol was synthesized via treatment of appropriately substituted 4-benzylamino-1,2,5,6-tetrahydropyridine-3-carboxamides with hydrogen sulfide and subsequent